. 2019 Dec 20;25(2):156–160. doi: 10.1634/theoncologist.2019-0542

Table 5.

Opioid doses used for breakthrough cancer pain in patients who were receiving low doses and high doses of opioids (L and H groups)

Opioids used for breakthrough pain	Mean dose (group L)	Mean dose (group H)	p value
OTFC	248 μg (137.09)	433 μg (290.26)	.0001
FBT	148 μg (72.05)	260 μg (194.53)	.0001
FBST	160 μg (96.29)	247 μg (177.41)	.0001
FPNS	118 μg (59.04)	187 μg (139.21)	.0001
INFS	75 μg (26.35)	106 μg (53.71)	.019
Oral morphine	8.75 mg (3.23)	14.62 mg (10.11)	.0001
Parenteral morphine	7.18 mg (3.29)	10.26 mg (6.28)	.0001

graphic file with name ONCO-25-156-g005.jpg

Standard deviation is in parentheses.

Abbreviations: FBST, sublingual fentanyl; FBT, fentanyl buccal tablet; FPNS, fentanyl pectin nasal spray; INFS, intransal fentanyl; OTFC, oral transmucosal fentanyl citrate.